Process development
Developing methodologies and processes for swift transition to production scale.
Our process development team draw on their adeno-associated viral vector (AAV) expertise in collaboration with our peer Innovation Hubs for Gene Therapies in London and Bristol to develop platform processes and methodologies. We innovate new technology to support our customers and research partners to optimise upstream and downstream processes and improve efficiency and reliability to deliver higher yields.
Working with R&D and Good Laboratory Practice (GLP) grades in our well equipped laboratories, we prepare customers' products and processes for larger scale technology transfer into our manufacturing facilities to provide materials for pharmacokinetic and toxicology studies, and clinical trials.
Analytical development
Using analytical platforms such as ELISA, ddPCR and developing analytical assays, we undertake investigations to improve titre, review yields and control impurities.